Advertisement

PharmacoResources

, Volume 24, Issue 1, pp 11–11 | Cite as

Cost-benefit argument favours medroxyprogesterone

Newsletter Article
  • 2 Downloads

Keywords

Endometrial Cancer Pyelonephritis Medroxyprogesterone Acute Pyelonephritis Daily Cost 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1995

Personalised recommendations